Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now shows the latest revision label as v3.6.5, replacing the previous v3.6.4. This reflects a metadata update to the study history rather than substantive content changes.SummaryDifference0.0%

- Check20 days agoChange DetectedNew history entries appear for 2026-08-01 and 2026-08-04 updating the Study Status and Contacts/Locations (versions 445 and 446). The 2026-07-02 entry is removed.SummaryDifference0.1%

- Check27 days agoChange DetectedA new revision label v3.6.4 appears in the history, replacing the previous v3.6.3. This indicates the page was updated to a newer build.SummaryDifference0.0%

- Check48 days agoChange DetectedA new version entry dated 2026-07-02 was added to the record history, updating the Study Status and Contacts/Locations sections (with an associated 2026-07-01 entry and a 444 marker). The 2026-06-15 entry was deleted.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision tag Revision: v3.6.3 was added to the record history and the older Revision: v3.6.0 tag was removed, updating the revision list shown for the study’s history.SummaryDifference0.0%

- Check63 days agoChange DetectedA new version entry (443) was added on 2026-06-12 introducing the Study Status and Contacts/Locations sections to the record history, and the last update date was set to 2026-06-15; a 2026-05-29 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.